Articles published by PharmAla Biotech
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
October 21, 2024
From PharmAla Biotech
Via GlobeNewswire
PharmAla Launches MDMA Clinical Trial Tool for Researchers
August 22, 2024
From PharmAla Biotech
Via GlobeNewswire
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
April 05, 2024
From PharmAla Biotech
Via GlobeNewswire
From PharmAla Biotech
Via GlobeNewswire
From PharmAla Biotech
Via GlobeNewswire
PharmAla receives new “MDXXF” ticker from FINRA for OTCQB Listing
January 24, 2024
From PharmAla Biotech
Via GlobeNewswire
Tickers
CSE:MDMA
From PharmAla Biotech
Via GlobeNewswire
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
July 31, 2023
From PharmAla Biotech
Via GlobeNewswire
From PharmAla Biotech
Via GlobeNewswire
From PharmAla Biotech
Via GlobeNewswire
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
February 03, 2023
From PharmAla Biotech
Via GlobeNewswire
Tickers
CSE:MDMA
Mindset Pharma and PharmAla Biotech Enter into Exclusive Sales Agreement
November 16, 2022
From PharmAla Biotech
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.